Carfilzomib potentiates CUDC-101-induced apoptosis in anaplastic thyroid cancer

Anaplastic thyroid cancer (ATC) is one of the most aggressive human malignancies, with no effective treatment currently available. Previously, we identified agents active against ATC cells, both in vitro and in vivo, using quantitative high-throughput screening of 3282 clinically approved drugs and...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Lisa, Boufraqech, Myriem, Lake, Ross, Kebebew, Electron
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4941332/
https://www.ncbi.nlm.nih.gov/pubmed/26934320
http://dx.doi.org/10.18632/oncotarget.7760

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4941332/
https://www.ncbi.nlm.nih.gov/pubmed/26934320
http://dx.doi.org/10.18632/oncotarget.7760

Ejemplares similares